User:Jeremiah C Hagler/SARS COV 2 RNA Replicase
From Proteopedia
(Difference between revisions)
Line 21: | Line 21: | ||
*6. Because viruses are not affected by antibiotics, researchers look for other drugs to stop viruses. Some of the promising anti-coronavirus drugs interact with RNA-dependent RNA polymerase. Why do you think this protein is a good target for drug development? If you were designing one of these drugs, specifically what kind(s) of interaction(s) would you look for? | *6. Because viruses are not affected by antibiotics, researchers look for other drugs to stop viruses. Some of the promising anti-coronavirus drugs interact with RNA-dependent RNA polymerase. Why do you think this protein is a good target for drug development? If you were designing one of these drugs, specifically what kind(s) of interaction(s) would you look for? | ||
- | *7. Take a look at this structure. You | + | *7. Take a look at this structure. You might notice that there is an additional organic molecule embedded in this structure (the big blobby molecule--it is being shown as a space-filling model rather than a cartoon or stick model like the rest of the molecules in this structure). This molecule is remdesivir. Remdesivir was considered a potential treatment for COVID-19. Take a look[https://www.nejm.org/doi/full/10.1056/NEJMoa2007764 link here] for an overview of a study that analyzed the impact of remdesivir on COVID-19 outcomes (just read the abstract). What do you think remdesivir is doing to inhibit the course of SARS-CoV-2 in at least some COVID-19 patients? |
== References == | == References == | ||
<references/> | <references/> |
Revision as of 01:13, 23 September 2020
SARS-COV-2 RNA-Dependent RNA Polymerase (Replicase)
|